**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 7790-84-3 |Cadmium sulfate, 8/3-hydrate | 100 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T N
Risk Phrases: 22 49 48/23/25 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. May cause cancer by inhalation. Toxic : danger
of serious damage to health by prolonged exposure through inhalation
and if swallowed. Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.Carcinogen.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause unconsciousness.
Inhalation:
Effects may be delayed. Causes respiratory tract irritation.
Irritation may lead to chemical pneumonitis and pulmonary edema. May
cause dyspnea (difficult or labored breathing). May cause cough,
chest pain, fever, muscular cramps, and headache.
Chronic:
May cause respiratory tract cancer. Prolonged or repeated exposure
may cause permanent bone structure abnormalities. May cause liver and
kidney damage. May cause anemia and other blood cell abnormalities.
Chronic inhalation may cause pulmonary emphysema. Chronic inhalation
may cause pulmonary fibrosis. Inhalation of dust may cause chronic
rhinitis (inflammation of the mucous membrane of the nose).
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Call a poison control center. If swallowed, do not induce vomiting
unless directed to do so by medical personnel. Never give anything by
mouth to an unconscious person. Get medical aid.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Antidote:
The use of Calcium disodium EDTA as a chelating agent should be
determined by qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash hands before eating. Minimize dust generation and accumulation.
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on
skin, or on clothing. Do not ingest or inhale. Use only in a
chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 7790-84-3:
United Kingdom, WEL - TWA: (listed as cadmium compounds): 0.025 m
TWA (except cadmium oxide fume, cadmium sulphide, cadmium sulphid
United Kingdom, WEL - STEL: (listed as cadmium compounds): 0.075
mg/m3 STEL (except cadmium oxide fume, cadmium sulphide, cadmium
sulphide
United States OSHA: 2.5 ??g/m3 Action Level (as Cd); 5 ??g/m3 PEL (
Cd. Do not eat, drink or chew t obacco or gum or apply cosmetics
regulated areas. Carcinogen: dust can cause lung and kidney
disease. See 29 CFR 1910.1027) (listed under Cadmium compounds).
Belgium - TWA: (listed as cadmium compounds): 0.002 mg/m3 VLE
(respirable particulates, as Cd); 0.01 mg/m3 VLE (inhalable part
France - VME: (listed as cadmium compounds): 0.05 mg/m3 VME (as C
Germany: (listed as cadmium compounds): 0.05 mg/m3 VME (as Cd)
Japan: (listed as cadmium compounds): 0.05 mg/m3 OEL (as Cd)
Malaysia: (listed as cadmium compounds): 0.01 mg/m3 TWA (as Cd);
0.002 mg/m3 TWA (respirable fraction, as Cd)
Russia: (listed as cadmium compounds): 0.05 mg/m3 TWA (as Cd)
Russia: (listed as cadmium compounds): 0.01 mg/m3 STEL (as Cd)
Spain: (listed as cadmium compounds): 0.01 mg/m3 VLA-ED (inhalabl
fraction, except cadmium sulfoselenide and cadmium
CAS# 10124-36-4:
United Kingdom, WEL - TWA: (listed as cadmium compounds): 0.025 m
TWA (except cadmium oxide fume, cadmium sulphide, cadmium sulphid
United Kingdom, WEL - STEL: (listed as cadmium compounds): 0.075
mg/m3 STEL (except cadmium oxide fume, cadmium sulphide, cadmium
sulphide
United States OSHA: 2.5 ??g/m3 Action Level (as Cd); 5 ??g/m3 PEL (
Cd. Do not eat, drink or chew t obacco or gum or apply cosmetics
regulated areas. Carcinogen: dust can cause lung and kidney
disease. See 29 CFR 1910.1027) (listed under Cadmium compounds).
Belgium - TWA: (listed as cadmium compounds): 0.002 mg/m3 VLE
(respirable particulates, as Cd); 0.01 mg/m3 VLE (inhalable part
France - VME: (listed as cadmium compounds): 0.05 mg/m3 VME (as C
Germany: (listed as cadmium compounds): 0.05 mg/m3 VME (as Cd)
Japan: (listed as cadmium compounds): 0.05 mg/m3 OEL (as Cd)
Malaysia: (listed as cadmium compounds): 0.01 mg/m3 TWA (as Cd);
0.002 mg/m3 TWA (respirable fraction, as Cd)
Russia: (listed as cadmium compounds): 0.05 mg/m3 TWA (as Cd)
Russia: (listed as cadmium compounds): 0.01 mg/m3 STEL (as Cd)
Spain: 0.01 mg/m3 VLA-ED (inhalable fraction, as Cd); 0.002 mg/m3
VLA-ED (respirable fr
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: odorless
pH: 3-6 (50g/l aq.sol.)
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 41 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: > 80 deg C
Solubility in water: 1130 g/l in water (20C)
Specific Gravity/Density:
Molecular Formula: Cd3O12S3.8H2O
Molecular Weight: 769.53
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Metals, oxidizing agents, zinc, selenium, tellurium, hydrogen azide,
Violently reacts with magnesium and with aluminum powder when
heated..
Hazardous Decomposition Products:
Oxides of sulfur, toxic cadmium oxide fumes.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 7790-84-3: EV2850000
CAS# 10124-36-4: EV2700000
LD50/LC50:
Not available.
CAS# 10124-36-4: Oral, mouse: LD50 = 47 mg/kg; Oral, rat: LD50 = 280
mg/kg.
Not available.
Carcinogenicity:
Cadmium sulfate, 8/3-hydrate -
California: carcinogen, initial date 10/1/87 (listed as Cadmium compou
NTP: Known carcinogen (listed as Cadmium compounds).
IARC: Group 1 carcinogen (listed as Cadmium compounds).
Cadmium sulfate -
California: carcinogen, initial date 10/1/87 (listed as Cadmium compou
NTP: Known carcinogen (listed as Cadmium compounds).
IARC: Group 1 carcinogen (listed as Cadmium compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing Group: III
IMO
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing Group: III
RID/ADR
Shipping Name: CADMIUM COMPOUND
Hazard Class: 6.1
UN Number: 2570
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 49 May cause cancer by inhalation.
R 22 Harmful if swallowed.
R 48/23/25 Toxic : danger of serious damage to
health by prolonged exposure through inhalation and if
swallowed.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 22 Do not breathe dust.
S 36/37 Wear suitable protective clothing and
gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 7790-84-3: No information available.
CAS# 10124-36-4: 3
Canada
CAS# 10124-36-4 is listed on Canada's DSL List.
CAS# 7790-84-3 is not listed on Canada's Ingredient Disclosure List.
CAS# 10124-36-4 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7790-84-3 is not listed on the TSCA inventory.
It is for research and development use only.
CAS# 10124-36-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 3/06/2000 Revision #3 Date: 12/28/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Hepes Sodium Salt, DNase, RNase and Protease Free, 99+%
| 75277-39-3 |
|
DL-alpha-Methylbenzylisothiocyanate, 98%
| 32393-32-1 |
|
Isopropanol, DNase, RNase, Protease free
| 67-63-0 |
|
Bromobenzene, 99%
| 108-86-1 |
|
Isopropyl-??-D-thiogalactopyranoside, DNase, RNase, Protease free,
| 123-91-1 |
|
Acetic Acid, Sodium Salt, Anhydrous, DNase, RNase, Protease Free
| 127-09-3 |
|
Bromoform, 99+%, Stabil. With 1 wt.% Ethanol
| 64-17-5 |
|
Buffer Solution pH 4
| 50-00-0 |
|
Sodium chloride, DNase, RNase, Protease free
| 7647-14-5 |
|
2-Butoxyethanol, 97%
| 111-76-2 |
|
Dodecyl sulfate, sodium salt, DNase, RNase, Protease free
| 151-21-3 |
|
Tris(hydroxymethyl)aminomethane,DNase,RNase,Protease free
| 77-86-1 |
|
Triton?? X-100, DNase, RNase, Protease free, peroxides free
| 9002-93-1 |
|
Cadmium chloride hemipentahydrate, reagent ACS, crystals
| 7790-78-5 |
|
Urea, DNase RNase and Protease free
| 57-13-6 |
|
25-Ethoxycalix[4]arene
| 138240-24-1 |
|
Cadmium nitrate tetrahydrate, reagent, crystals, 99%
| 10022-68-1 |
|
(S)-(+)-Tetrahydro-5-Oxo-2-Furanecarboxylic Acid, 98%
| 21461-84-7 |
|
25,27-Dipropoxycalix[4]Arene, 95%
| 162301-48-6 |
|
25,26,27,28-Tetrapropoxycalix[4]Arene, 98%
| 0-01-1 |
|
Cadmium sulfate, 8/3-hydrate, reagent acs, crystals
| 7790-84-3 |
|
5-Bromo-25,26,27,28-Tetrapropoxycalix[4]Arene, 97%
| 0-01-1 |
|
Caffeine, 98% (Titr.)
| 58-08-2 |
|
5,11,17,23-Tetrabromo-25,26,27,28-tetrapropoxycalix[4]arene, 98%
| 181640-72-2 |
|
Calcium hydride, CA. 93%, 0-2 mm Grain size
| 7789-78-8 |
|
Acrylamide
| 79-06-1 |
|
5,11-Dibromo-25,27-Dipropoxycalix[4]arene, 99%
| 176098-88-7 |
|
25-Ethoxy-27-Diethoxyphosphoryloxycalix[4]Arene
| 0-01-1 |
|
5,11,17,23-Tetrakis-dimethylaminomethylcalix[4]arene
| 115421-52-8 |
|
Trifluoroacetylisocyanate
| 14565-32-3 |
|
C-Undecylcalix[4]resorcinarene Monohydrate
| 0-01-1 |
|
Sodium tert-Pentoxide, 95%
| 14593-46-5 |
|
2-Phenylpropyl butyrate, 98%
| 80866-83-7 |
|
Diisopropyl Azodicarboxylate, 94%
| 2446-83-5 |
|
5-Fluoroorotic Acid Hydrate, 98%
| 703-95-7 |
|
Poly-L-leucine
| 0-01-1 |
|
2-Nitrochalcone
| 7473-93-0 |
|
Calcium hydroxide, reagent ACS
| 1305-62-0 |
|
4-Methoxychalcone
| 959-33-1 |
|
Calcium lactacte pentahydrate (powder), 98% (titr.)
| 5743-47-5 |
|
Ethyl stearate, mixture 1:1 with ethyl palmitate
| 111-61-5 |
|
MOPS, DNase, RNase, Protease Free
| 1132-61-2 |
|
(R)-(+)-Carbobenzyloxyamino-3-Phenyl-1-Propanol
| 58917-85-4 |
|
Bafilomycin A1
| 88899-55-2 |
|
2,6-Dichloro-5-Fluoronicotinoyl Chloride, 90%
| 96568-02-4 |
|
Methyl Indole-4-Carboxylate
| 39830-66-5 |
|
2134800 Phosphate, dibasic, anhydrous, 97+%
| 7757-93-9 |
|
N-BOC Ethyl Oxamate
| 0-01-1 |
|
3-(4-Methylbenzoyl)Propionic Acid, 98%
| 4619-20-9 |
|
4-(4-Methylphenyl)Butyric Acid, 98%
| 4521-22-6 |
|
|